Clinical Trials on ALK Genomic Tumor Aberrations in China

Total 2227 results

Peking Union Medical College Hospital

Recruiting

Prediction and Evaluation of Anlotinib Treatment Response Using Contrast Enhanced Ultrasound PPGL Patients

Ultrasonography | Pheochromocytoma, Metastatic | Paraganglioma, Malignant | Pheochromocytoma Malignant

China
Xinhua Hospital, Shanghai Jiao Tong University...

Unknown

Study of Tomotherapy HD in Medulloblastoma

Medulloblastoma

China
Children's Hospital of Fudan University
Second Affiliated Hospital of Wenzhou Medical University; Guangzhou Women and... and other collaborators

Recruiting

Genomic Sequencing and Personalized Treatment for Birth Defects in Neonatal Intensive Care Units

Genetic Disease | Congenital Malformation | Multiple Malformation

China
Zhejiang University

Recruiting

Enucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric Artery

Surgical Blood Loss | Tumor of Pancreas

China
Second Affiliated Hospital, School of Medicine,...

Not yet recruiting

Tranexamic Acid Use for Bleeding Prevention in the Surgical Treatment of Metastatic Spinal Tumor in Lung Cancer Patients

Metastasis Spinal Tumor

China
Merck Sharp & Dohme LLC

Active, not recruiting

Immunobridging Study of 9- Valent Human Papillomavirus (9vHPV) Vaccine (V503) in Chinese Females 9 to 45 Years of Age (V503-024)

Papillomavirus Infections

China
Bristol-Myers Squibb

Completed

Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia

Chronic Myeloid Leukemia | Philadelphia-Positive Myeloid Leukemia

Belgium, Spain, United States, Italy, Argentina, Brazil, Canada, Germany, Peru, Puerto Rico, Singapore, South Africa, Taiwan, United Kingdom, Australia, France, Philippines, Sweden, Thailand, Russian Federation, China, Poland, Finland, Isra... and more
Genor Biopharma Co., Ltd.

Recruiting

Phase I Clinical Trial in Chinese Patients of Advanced and (or) Recurrent Solid Tumor/Lymphoma (GB226)

Lymphoma | Advanced Solid Tumor | Recurrent Solid Tumor | Recurrent Lymphocyte Depleted Classical Hodgkin Lymphoma

China
Westlake Therapeutics

Recruiting

Safety, Tolerability and Preliminary Efficacy of Engineered Red Blood Cell in Patients With Advanced Malignancies (Reboot-101)

Cancer | Solid Tumor | Hematologic Malignancy

China
Henan Cancer Hospital

Recruiting

Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors

Depression | Anxiety | Malignant Tumor

China
Tongji Hospital

Unknown

Comparing Three Dimension Laparoscopic Versus Open Surgery for Perihiliar Cholangiocarcinoma

Surgery | Cholangiocarcinoma, Perihilar

China
Novartis Pharmaceuticals

Recruiting

Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

Myeloid Leukemia, Philadelphia Positive

Korea, Republic of, Germany, France, Greece, Hungary, Italy, Japan, Russian Federation, Thailand, Turkey, China, United States, Netherlands, Poland
Shanghai Bovax Biotechnology Co., Ltd.

Completed

A Phase I Study of Quadrivalent HPV Recombinant Vaccine

HPV Infections

China
Henan Cancer Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Clinical Study of Apatinib as the Second-line Therapy in Malignant Melanoma

Malignant Melanoma

China
Peking University
Novartis

Completed

Trial of Imatinib (Gleevec®) in Selected Patients With Metastatic Melanoma

Metastatic Melanoma

China
Merck Sharp & Dohme LLC

Active, not recruiting

V503 in Chinese Girls 9-14 Years Old Versus Chinese Women 20-26 Years Old (V503-071)

Papillomavirus Infections

China
Suzhou Genhouse Bio Co., Ltd.

Active, not recruiting

Dose Finding Study of GH35 in Patients With Advanced Solid Tumors

AdvAdvanced Solid Tumors | Kirsten Rat Sarcoma

China
SYZ Cell Therapy Co..

Completed

MASCT-I in Patients With Metastatic or Recurrent Solid Tumors Who Failed Standard Therapy.

Solid Tumors

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Comparison of Autogenic and Allogenic NK Immunotherapy on the Outcome of Recurrent Solid Tumors

Malignant Solid Tumour

China
Chinese PLA General Hospital

Recruiting

Comparison of Microwave Ablation With Breast Conserving Surgery for Breast Tumor

Breast Tumor | Microwave Ablation | Breast Conserving Surgery

China
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Tianjin Medical University Cancer Institute and Hospital; Shandong Cancer Hospital...

Recruiting

TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma

B7-H3-positive Relapsed/ Refractory Neuroblastoma

China
Peking University

Terminated

Study to Compare Irinotecan Combined With Cisplatin (IP) Versus Etoposide Combined With Cisplatin (EP) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Carcinoma

Neuroendocrine Carcinoma

China
Peking University

Unknown

Study to Evaluate the Efficiency of SOX as Seconde-line Chemotherapy in Neuroendocrine Carcinoma

Neuroendocrine Carcinoma

China
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Recruiting

Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma.

Neuroendocrine Carcinoma

China
Binhui Biopharmaceutical Co., Ltd.

Recruiting

OH2 Injection in Combination With HX008 for Melanoma.

Melanoma

China
Peking University

Unknown

Study to Evaluate the Efficiency of FOLFIRI as Seconde-line Chemotherapy in Neuroendocrine Carcinoma

Neuroendocrine Carcinoma

China
Di Wu

Recruiting

Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma

Acral Melanoma

China
Hoffmann-La Roche

Completed

A Study of Vemurafenib (Zelboraf) in Chinese Participants With BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma

Malignant Melanoma

China
Henan Cancer Hospital

Recruiting

PD-1 Antibody Tislelizumab Combined With Dacarbazine in the Treatment of Advanced Melanoma

Advanced Melanoma

China
First Affiliated Hospital of Zhejiang University

Recruiting

A Study of Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant Melanoma

Malignant Melanoma

China
Timmune Biotech Inc.
The Second Affiliated Hospital of Hainan Medical University; Hainan Cancer...

Unknown

Treatment of Malignant Melanoma With GPA-TriMAR-T Cell Therapy

Malignant Melanoma

China
Sun Yat-sen University

Unknown

Mucosal Melanoma of Head and Neck in Intensity-modulated Radiotherapy Era

Mucosal Melanoma

China
Beijing Tiantan Hospital

Recruiting

Prospective Study on Quality of Life in Patients With Intracranial Germ Cell Tumors

Quality of Life

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Technological Development and Clinical Parallel Testing of PGT-G

Genetic Disease

China
Shanghai YingLi Pharmaceutical Co. Ltd.

Recruiting

A Study of YL-17231 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Huazhong University of Science and Technology

Unknown

A Trial to Compare Surgery With Sorafenib for Hepatic Celluler Cancer With Portal Vein Tumor Thrombosis

Portal Vein Tumor Thrombus

China
Peking Union Medical College Hospital

Unknown

Recurrence Rates of Type I Gastric Neuroendocrine Tumors Treated With Long-acting Somatostatin Analogs

Gastric NET

China
Guangdong Provincial People's Hospital

Completed

Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma Recurrence

Hepatocellular Carcinoma | Circulating Tumor Cell;

China
Sichuan Baili Pharmaceutical Co., Ltd.
SystImmune Inc.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

Recruiting

A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Urological Tumors and Other Solid Tumors

Locally Advanced or Metastatic Urinary Tumors | Other Solid Tumors

China
Chongqing Precision Biotech Co., Ltd

Recruiting

Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer

Renal Cell Carcinoma | Advanced Cancer | Metastatic Tumor

China
HC Biopharma Inc.

Recruiting

A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
First Affiliated Hospital Xi'an Jiaotong University

Not yet recruiting

Characteristics of Cardiac Tumor and the Risk Stratification of Subsequent Adverse Events (UNIQUE) (UNIQUE)

Cardiac Tumor

China
Taizhou EOC Pharma Co., Ltd.

Unknown

Study of EOC317 in Chinese Patients With Advanced Solid Tumors

Solid Tumor

China
Nanjing First Hospital, Nanjing Medical University

Recruiting

A Prospective Phase II Efficacy and Safety Study of Anlotinib in Metastatic or Locally Advanced Pheochromocytoma/ Paraganglioma : Open-label Single-arm, Exploratory Trial (EASOAIPPGL)

Advanced or Metastatic Paraganglioma/ Pheochromocytoma

China
The University of Hong Kong

Recruiting

Effects of TIVA Versus Inhalational Anaesthesia on Circulating Tumour Cells in Hepatocellular Carcinoma Patients

Hepatocellular Carcinoma | Circulating Tumor Cell

China
L & L biopharma Co., Ltd., Shanghai China

Recruiting

A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma（Keyplus-001）

Lymphoma | Solid Tumor

China
Chinese PLA General Hospital

Recruiting

An Open-label, Phase I/II Study of Manganese Plus Radiotherapy in Patients With Metastatic Solid Tumors or Lymphoma

Lymphoma | Solid Tumor

China
Guangzhou Virotech Pharmaceutical Co., Ltd.

Recruiting

A Study of Intravenous M1-c6v1 for Locally Advanced or Metastatic Solid Tumors

Solid Tumor

Japan
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Anti-PD-1 and NK Immunotherapy for Recurrent Solid Tumors

Malignant Solid Tumour

China
HitGen Inc.

Recruiting

Clinical Trial of HG146 Administered to Subjects With Advanced Solid Tumors or Lymphoma

Lymphoma | Solid Tumor

China

Clinical Trials on ALK Genomic Tumor Aberrations in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations